Definitive Healthcare Corp (DH)vsVeeva Systems Inc Class A (VEEV)
DH
Definitive Healthcare Corp
$0.89
-1.11%
HEALTHCARE · Cap: $112.08M
VEEV
Veeva Systems Inc Class A
$260.91
-0.15%
HEALTHCARE · Cap: $42.13B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 1386% more annual revenue ($3.46B vs $232.70M). VEEV leads profitability with a 29.3% profit margin vs -72.3%. VEEV earns a higher WallStSmart Score of 66/100 (B-).
DH
Hold37
out of 100
Grade: F
VEEV
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+76.2%
Fair Value
$7.09
Current Price
$0.89
$6.20 discount
Margin of Safety
+41.1%
Fair Value
$300.79
Current Price
$260.91
$39.88 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 29 of every $100 in revenue as profit
Strong operational efficiency at 29.6%
17.6% revenue growth
Earnings expanding 39.5% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -116.5% — below average capital efficiency
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book.
Bull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 29.3% and operating margin at 29.6%. Revenue growth of 17.6% demonstrates continued momentum.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Debt/Equity.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio. A P/E of 42.7x leaves little room for execution misses.
Key Dynamics to Monitor
DH profiles as a turnaround stock while VEEV is a growth play — different risk/reward profiles.
DH carries more volatility with a beta of 1.40 — expect wider price swings.
VEEV is growing revenue faster at 17.6% — sustainability is the question.
VEEV generates stronger free cash flow (231M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (66/100 vs 37/100), backed by strong 29.3% margins and 17.6% revenue growth. DH offers better value entry with a 76.2% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a leading provider of comprehensive data and analytics solutions designed specifically for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and cutting-edge real-time analytics, Definitive Healthcare enhances operational efficiencies and delivers critical strategic insights, ultimately improving patient outcomes. With a strong commitment to innovation, the company is well-positioned to capitalize on the growing demand for sophisticated healthcare analytics, thereby establishing itself as a pivotal player in the transformation of healthcare delivery.
Visit Website →Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?